Bevacizumab, 25 mg

Bevacizumab is utilized in controlled chemical reactions and formulations, identified as a compound belonging to the monoclonal antibody class with a molecular formula of C16H21NO3 and a molecular weight of 275.34. Its structure suggests it may function as an immunomodulator, binding specifically to vascular endothelial growth factor (VEGF) to inhibit angiogenesis. As a result, it carries a Warning signal word due to potential harm if ingested. Bevacizumab also exhibits a high affinity for VEGF, which plays a critical role in tumor growth and metastasis, making it a valuable therapeutic agent in the treatment of various cancers.

• CAS Number: 216974-75-3
• Exact Mass: 275.15214353
• Molecular Formula: C16H21NO3
• Molecular Weight: 275.34
• GHS Signal Word: Warning
• Hazard Statements:
• H302: Harmful if swallowed [Warning Acute toxicity, oral]